大三学生叶不凡，为了给母亲筹集医药费碰瓷，不料遇到不按套路出牌的女司机，被撞之后的叶不凡无意中穿越到幻境，获得了古医门的传承，从此精通医术、修炼功法，获得无数美女青睐。
在这个世界上有一群人，他们身体上刻有文字“印”，并可以通过念力将“印”转化为超能力施放出来，这种能力被称为言能，而这群人被称为言能师。唯一能够教授这种能力知识的地方，是有着悠久历史，继承了远古文明的万象学城。每一年万象学城都会举办考试，招收有潜力的言能师进入学城学习，并将他们组建成维护世界和平的警卫力量——千从狩。我们的主人公千从虽是个有印无能的哑炮，却也梦想着成为最强的千从狩，并为此进入学城求学，开启了他的不灭人生。
TV动画『IDOLiSH7 -偶像星愿-』2期制作决定！制作公司依旧是TROYCA！十二位偶像的故事再度展开！
FOX宣布《辛普森一家》续订第33、34季，也就是到2023年，集数将达757集，继续保持并刷新美剧史上“播出时间最长的黄金时段有剧本剧集”记录。
为揭开秦烈里魂的秘密，本季中时光将回朔到秦烈刚刚加入器具宗外宗之时。彼时秦烈经李牧指点，为了寻找凌语诗，秦烈排除障碍通过了器具宗试炼，加入外宗。在唐思琪的指点下开始进行日常修炼。 由于在入宗考试中惹恼了唐思琪，秦烈在宗门内的生活处处被大师姐刁难。天长日久，二人之间竟然产生了一些不可名状的情愫。而这些也都被意图篡取宗门之位的梁少扬看在了眼里。期初梁少扬只是为了宗主之位接近唐思琪，但经过一段日子的接触，梁少扬也对大师姐产生了特殊的感觉……
By daylight, Marinette Dupain-Cheng and Adrien Agreste are ordinary teenagers. But unbeknownst to their family and friends, the two of them carry a huge secret...using the powers of magical creatures called Kwami, they transform into the superheroes Ladybug and Cat Noir! With a mission to protect the city of Paris from the evil Hawk Moth, the two of them must learn to cope with their new responsibilities, as well as ordinary troubles involving love, school, family, and friends. Most of all, they must learn to put their romantic feelings aside in order to perform their duty, unaware of each other's true identities. The second season premiere is scheduled for a global launch around September–November 2017 in Europe, At a panel at San Diego Comic-Con 2017, it was announced that the second season would have its North American release on Netflix in December 2017, with 13 episodes to be released. KidsClick will start airing season 2 of this show in the US starting 30 August 2018, marking the first time that Season 2 of this show airing on American over-the-air television. A third season is also in development. On 22 January 2018, Zag posted on Instagram that the crew was working on a fourth and fifth season. On 31 August premiered a new series with Miraculous: Tales of Ladybug & Cat Noir which this time is in chibi style. On 5 September, 2018, Skydance Media has acquired the live-action film and live-action television rights.
